Emergent Biosolutions EBS Operating margin

Operating margin at other companies

Thermo Fisher ScientificTMO

17.2%+0.8pp

Regeneron PharmaceuticalsREGN

24.7%-2.3pp

SIGA TechnologiesSIGA

52.4%-7.8pp

AMP

Amphastar PharmaceuticalsAMPH

15.7%-9.5pp

Amneal Pharmaceuticals, Inc.AMRX

14.6%+1.4pp

Lifecore Biomedical, Inc.LFCR

-13.4%—

FAQ

What is Emergent Biosolutions's operating margin?

Emergent Biosolutions (EBS) reported operating margin of 15% in Q3 2025.

How has Emergent Biosolutions's operating margin changed year-over-year?

Emergent Biosolutions's operating margin increased by 218.2% year-over-year, from -12.7% to 15%.

What is the long-term trend for Emergent Biosolutions's operating margin?

Over 4 years (2020 to 2024), Emergent Biosolutions's operating margin has grown at a -21.8% compound annual growth rate (CAGR), from 27.9% to -10.4%.

What does operating margin mean?

Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.